The preliminary agenda for the 17th World ADC San Diego, taking place October 12–15, 2026, has been released, offering an exclusive first look at the scientific program for the world’s definitive antibody–drug conjugate (ADC) industry meeting.
Returning as the global orientation point for ADC innovation, World ADC San Diego continues to redefine oncology’s therapeutic impact. As antibody–drug conjugates further establish themselves as a go-to modality in oncology, the conference convenes the global ADC community to shape the next standard of care across oncology and beyond.
The 2026 preliminary agenda features top-tier ADC leaders and experts from AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Innovent Biologics, Pfizer, Tubulis, among others. Over the course of an unmissable week, speakers will share critical data, insights, and strategies designed to translate ADC innovation into differentiated, early-line patient outcomes.
World ADC San Diego 2026 at a glance:
- 1,300+ industry attendees from leading biopharma companies, innovative start-ups, specialized service providers, and academic, physician, and regulatory key opinion leaders
- 400+ companies represented, marking the largest annual convergence of the global ADC ecosystem
- 170+ world-class speakers addressing innovation opportunities and development bottlenecks to secure early-line ADC patient impact
- 7 parallel scientific tracks covering end-to-end ADC development, from discovery through late-stage manufacturing
- A dedicated Pre-Conference Seminar Day exploring ADC novelty, bottlenecks, and advancement
- An interactive Post-Conference Workshop Day enabling peer-led discussions and practical problem-solving with ADC KOLs
- 17 hours of structured and informal networking designed to foster new collaborations across ADC biopharma and service providers
The four-day agenda offers attendees a comprehensive view of end-to-end innovation, paired with unparalleled opportunities for scientific exchange and strategic networking.
With the entire ADC ecosystem uniting under one roof, World ADC San Diego remains the essential forum to innovate, collaborate, and help redefine the future standard of oncology care.
For more information and to view the preliminary agenda, visit World ADC San Diego. https://ter.li/ey8p38nt